Recent Insider Transactions - Halozyme Therapeutics (NASDAQ: HALO)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ HALO Halozyme Therapeutics

Henderson Jeffrey William / director

04/01/2025

Sell

$64.05

503

$32K

33,108

NASDAQ HALO Halozyme Therapeutics

Henderson Jeffrey William / director

03/03/2025

Sell

$57.93

1,795

$104K

36,816

NASDAQ HALO Halozyme Therapeutics

Henderson Jeffrey William / director

03/03/2025

Sell

$59.12

3,205

$189K

33,611

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/25/2025

Sell

$58.01

9,300

$539K

186,153

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/25/2025

Sell

$58.67

700

$41K

185,453

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/26/2025

Sell

$58.09

9,400

$546K

176,053

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/26/2025

Sell

$58.65

600

$35K

175,453

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/27/2025

Sell

$58.25

1,597

$93K

173,856

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/27/2025

Sell

$58.74

100

$6K

173,756

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/23/2025

Sell

$57.75

2,410

$139K

195,453

NASDAQ HALO Halozyme Therapeutics

Snyder Mark Howard / officer: SVP, CHIEF LEGAL OFFICER

02/23/2025

Sell

$57.75

3,775

$218K

28,489

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/23/2025

Sell

$57.75

3,601

$208K

31,900

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/23/2025

Sell

$57.75

12,081

$698K

733,719

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/20/2025

Buy

$57.44

11,902

$684K

11,902

NASDAQ HALO Halozyme Therapeutics

Snyder Mark Howard / officer: SVP, CHIEF LEGAL OFFICER

02/20/2025

Buy

$57.44

22,603

$1.298M

22,603

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/20/2025

Buy

$57.44

22,603

$1.298M

22,603

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/20/2025

Buy

$57.44

71,038

$4.080M

71,038

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/16/2025

Sell

$58.29

2,164

$126K

193,116

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/16/2025

Sell

$58.29

3,103

$181K

191,017

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/16/2025

Sell

$58.29

8,721

$508K

188,008

NASDAQ HALO Halozyme Therapeutics

LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER

02/15/2025

Sell

$58.29

1,304

$76K

175,838

NASDAQ HALO Halozyme Therapeutics

Snyder Mark Howard / officer: SVP, CHIEF LEGAL OFFICER

02/16/2025

Sell

$58.29

2,582

$151K

25,252

NASDAQ HALO Halozyme Therapeutics

Snyder Mark Howard / officer: SVP, CHIEF LEGAL OFFICER

02/16/2025

Sell

$58.29

9,373

$546K

23,038

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/16/2025

Sell

$58.29

2,869

$167K

28,813

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/16/2025

Sell

$58.29

2,742

$160K

26,353

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/16/2025

Sell

$58.29

9,400

$548K

24,002

NASDAQ HALO Halozyme Therapeutics

LaBrosse Nicole / officer: SVP, CHIEF FINANCIAL OFFICER

02/15/2025

Sell

$58.29

741

$43K

15,993

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/16/2025

Sell

$58.29

9,087

$530K

723,364

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/16/2025

Sell

$58.29

11,313

$659K

715,576

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/16/2025

Sell

$58.29

38,668

$2.254M

705,880

NASDAQ HALO Halozyme Therapeutics

Torley Helen / director, officer: PRESIDENT AND CEO

02/15/2025

Sell

$58.29

7,098

$414K

672,738